发明名称 |
Use of a tetrasubstituted pyrazolo(4,3-d)pyrimidine compound for treating diabetic nephropathy |
摘要 |
The present invention relates to methods of delaying progression to end stage renal disease (ESRD) in patients comprising administration of 1-(2-ethoxyethyl)-5-(ethyl(methyl)amino)-7-((4-methylpyridin-2-yl)amino)-N-(methylsulfonyl)-1H-pyrazolo[4,3-d]pyrimidine-3-carboxamide. The present invention also includes administration of pharmaceutical compositions for delaying progression to ESRD. 1-(2-ethoxyethyl)-5-(ethyl(methyl)amino)-7-((4-methylpyridin-2-yl)amino)-N-(methylsulfonyl)-1H-pyrazolo[4,3-d]pyrimidine-3-carboxamide. |
申请公布号 |
AU2013336293(B2) |
申请公布日期 |
2016.05.12 |
申请号 |
AU20130336293 |
申请日期 |
2013.10.09 |
申请人 |
PFIZER INC. |
发明人 |
CLERIN, VALERIE;GALE, JEREMY;TAMIMI, NIHAD |
分类号 |
A61K31/519;A61P13/12 |
主分类号 |
A61K31/519 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|